http://www.onemedplace.com/blog/wp-content/uploads/2009/10/onsolis.jpg
BDSI focuses on the niche market of pain management and supportive cancer care.
View ArticlePR Newswire: BioDelivery Sciences International Secures $20 Million in Debt...
A company to keep a look out for in the upcoming future is BioDelivery Sciences International (BDSI), a specialty pharmaceutical company with a platform of drug delivery technologies to develop,...
View Article